Waterfield Advisors Equities Head Suggests Staggered Accumulation as Macro Concerns Ease Bayer CropScience Q4 Net Profit Rises 13 to 162 Crore on Revenue Growth Jim Cramers Bold Statement on CrowdStrike Draws Market Attention Jim Cramer Advises Investors to Focus on AI Stocks Upside Potential Not Past Performance AIDriven NBFCs Reshaping Indias Credit Landscape with Intelligent Lending Goldman Sachs Sees Limited Impact From Latest US Sanctions on Russian Oil Exports ELDN Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates Amid Ongoing Development Costs MGX Q1 2026 Earnings Missed Expectations as PreRevenue Biotech Advances Gene Editing Pipeline EYPT Q1 2026 Earnings WiderthanExpected Loss as Company Advances Clinical Pipeline KLIC Q1 2026 Earnings EPS Surges Past Estimates as Semiconductor Capital Equipment Demand Strengthens BDTX Q1 2026 Earnings EPS Beat but Stock Retreats 36 on Biotech Volatility RYM Q3 2022 Earnings Deep Earnings Miss Amid Negative Surprise Materion Corporation MTRN Holds Steady Near Support Amid Marginal Decline NeuroOne Medical Technologies NMTC Drops 538 as Stock Approaches Key Support Resideo Technologies REZI Edges Higher as Momentum Shifts Toward Resistance Abivax ABVX Holds Steady Near Support Amid Narrow Trading Range TEN Holdings Inc XHLD Slips 27 as Stock Hovers Near Support Levels Jardine Matheson Acquires Australian Imaging Firm IMED in 31 Billion Deal SLS Q1 2026 Earnings WiderThanExpected Loss as Clinical Milestones Remain the Focus LM Funding America LMFA Edges Higher at 024 Testing Key Resistance Amid Low Volatility General Motors Expands Luxury EV Lineup with Cadillac Vistiq Targeting 300Mile Range US Pressure Campaign Against Cuba May Signal Heightened Geopolitical Risks Gold and Silver Decline as Precious Metals Retreat from Recent Highs Tipco Engineering Posts More Than Double Net Profit on Robust Demand Revenue Surges 66 Piper Sandler Warns Strait of Hormuz Closure Could Last Months Push Oil to New Highs Should a 63YearOld With 14 Million Convert to a Roth While Expecting to Live to 100 Novartis Lifts FullYear Sales and Profit Outlook